Chronic skin diseases such as psoriasis (itchy, scaly skin patches), eczema (long-term skin allergy), and hidradenitis ...

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

The inspiration for her business, which is called Granlab, came from watching her grandmother experience excruciating ...

STRATA Skin Sciences' Q2 2025 earnings call reveals CPT code expansion tripling patient reach, driving growth potential amid legal, tariff, ...

STRATA Skin Sciences(NASDAQ:SSKN) reported its second-quarter 2025 results on August 13, 2025, highlighting significant developments in reimbursement expansion, ongoing litigation, and commercial ...

GAAP revenue was $2.7 million for Q2 2025, missing analyst estimates by 20.6%. Operating expenses surged, driven by costs tied to the ACELYRIN merger and clinical trial acceleration. The merger ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated diseases, today reported financial results for ...

Magnesium is having a moment. And when it comes to skin care, this mineral could have major benefits. But evidence for transdermal magnesium is limited.

Large cohort study finds TNF inhibitors linked to lower cancer risk in psoriasis, supporting long-term safety of biologic ...